Pfizer AG - Harmonet, überzogene Tabletten | | 53394 | | 01 | | Harmonet | | überzogene Tabletten | | G03AA10 | | Gestodene and Ethinylestradiol | | 03.09.1997 | | |
| Composition | gestodenum 75 µg, ethinylestradiolum 20 µg, lactosum monohydricum 37.505 mg, maydis amylum, povidonum K 25, magnesii stearas, Überzug: saccharum 19.66 mg, povidonum K 90, macrogolum 6000, calcii carbonas, talcum, cera montanglycoli, pro compresso obducto. | Packungsbestandteile | | überzogene Tabletten | | Active Agent | Dose |
---|
Ethinyl Estradiol | 20 µg | Gestoden | 75 µg |
| | Inactive agents | Dose | additional_information |
---|
Calcium Carbonate | | | Cera Montanglycoli | | | Lactose Monohydrate | 37.505 mg | | Macrogol | 6000 | | Magnesii Stearas | | | Maydis Amylum | | | Povidonum K | 90 | | Pro Compresso Obducto | | | Saccharum | 19.66 mg | Überzug | Talcum | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
019 | 21 Dragée(s) | PR | 19.90 | B | | Yes | 027 | 3 x 21 Dragée(s) | PR | 57.65 | B | | Yes | 035 | 6 x 21 Dragée(s) | PR | 110.75 | B | | Yes |
|
|